Alfred Horhey

Doctor of Medicine,  Cleveland Clinic 

Location: India

Consulting Services

Pharma-CRO-Device Scientific Writing Legal Support

Areas Of Interest

Laboratory Animal Sciences PHQ-9 Ambulances, Helicopter Inhibitors, CYP2C9 Pulsion Diverticulum, Pharyngoesophageal Accident and Emergency Department Tremorine Narwhal Clinical Study Technique, Surgical Closure Optic Lobes, Human Anhydrous Saralasin Acetate Frontal Cortices S-Adenosylmethionine Protein Carboxymethyltransferase Aggrenox Isoleucyl(5)-Angiotensin II Cancers, Thymus GTPase Linked Elongation Factors beta-Adrenergic Blockers Health Services Overuse Capsule Endoscopies, Wireless Research, Comparative Effectiveness Device Exemption, Humanitarian Tylophora indica Class Ia Phosphatidylinositol 3 Kinase, p50alpha Subunit p120rasGAP Pharmacists Aides GR43175 Wandering, Nocturnal Epidermophytons Capuchin, White-Throated Nerves, Perineal Multiple Carboxylase Deficiency, Late Onset

Professional Narrative

Dr. Alfred Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Assistant Professor, Harvard Med 2012
Assistant Professor, Harvard Med 1990

Education

Doctor of medicine, Perelman School of Medicine 2000
Doctor of medicine, Yale School of Medicine 2009

Referees

Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02